1 / 16

Introduction, Background and Potential of Biological Weapons

Introduction, Background and Potential of Biological Weapons. Part 1 of 13 Comments and contributions are encouraged: please e-mail D Rcomments@hpa.org.uk. HPA Centre for Infections. Reviewed April 2009. Bioterrorism: sets of slides in this series.

mervin
Télécharger la présentation

Introduction, Background and Potential of Biological Weapons

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Introduction, Background and Potential of Biological Weapons Part 1 of 13 Comments and contributions are encouraged: please e-mailDRcomments@hpa.org.uk HPA Centre for Infections Reviewed April 2009

  2. Bioterrorism: sets of slides in this series • Introduction, background and potential of biological weapons • Clinical scenarios • 3. Syndromic presentations • 4 - 9. The top six Agents: anthrax, plague, smallpox/ summary of the smallpox plan, botulism, VHF, tularemia • 10. What to do • 11. Sources of information • 12. Unusual illnesses

  3. History of Biowarfare (BW) (1) • 14th. C - siege of Kaffa (plague infected bodies) • 18th. C - smallpox infected blankets to Indians • WWI - German sabotage in neutral countries • 1925 - Geneva Protocol • 1932  1945 - Japan’s Unit 731 in Manchuria

  4. History of BW (2) • WWII to the end of the Cold War - USA, Canada and UK had BW programs • Nixon’s statement to Congress 1969 • 1972 - Biological And Toxic Weapons Convention (BTWC - now ratified by >140 countries)

  5. 1972 - signed BTWC 1973 - Biopreparat 55,000 staff 52 establishments Field test site on Vozrozhdeniye (Rebirth) island, Aral Sea Smallpox, anthrax, plague, tularemia, glanders,VEE, Marburg BW in USSR • Map of defence establishments including CBRN (CIA website,www.cia.gov)

  6. The Potential of Bioterrorism • Cheap (low cost/kill ratio) • Simple to produce (but not to deliver) • Defense is difficult • Expertise available • PUBLIC PANIC • Devastating effect • Terrain denying

  7. Aum Shinrikyo and the Tokyo Subway Incident • 1995; sarin nerve gas released on Tokyo Metro • 12 killed; 5,000 injured • Research on anthrax, botulinum and Q fever • 8 abortive biological attacks (anthrax) • Attempt to obtain Ebola in Zaire • Aircraft equipped with spray tanks

  8. The Potential of Bioterrorism Agent Lethal infective doses in 5mls Cyanide 50 Mustard gas 100 Sarin 5,000 Botulinum toxin 1,000,000 Anthrax 50,000,000, Tularemia 50,000 x 106

  9. A release of 50 kg agent in an area with population 5 million…. Anthrax 250,000 cases 100,000 deaths Plague 150,000 cases 36,000 deaths Tularemia 250,000 cases 19,000 deaths Worst case scenarioWHO Estimates, 1970

  10. Features Easily disseminated or transmitted person - person High mortality – major public health impact Public panic and social disruption Special action for public health preparedness Agents Anthrax Plague Smallpox Tularemia Viral haemorrhagic fevers Botulinum toxin Potential BW Agents: CDC Category A

  11. Features Moderately easy to disseminate Moderate morbidity, low mortality Require enhancement of diagnostic capacity and surveillance Agents Q fever Brucellosis Glanders & melioidosis VEE, EEE and WEE Enteric pathogens Other toxins Potential BW Agents: CDC Category B

  12. Features Emerging agents Availability Easy to produce and disseminate Potential for high mortality and morbidity Agents Nipah virus Hantaviruses Tickborne HF Tickborne encephalitis Yellow fever MDRTB Potential BW Agents: CDC Category C

  13. CDC Category A ANTHRAX PLAGUE SMALLPOX BOTULISM Tularemia Viral haemorrhagic fevers & encephalitides Agents of Bioterrorism- the Main Suspects

  14. OVERT Hoaxes & false alarms Genuine Early recognition Police COVERT Delayed recognition Health Care Staff Types of Deliberate Release

  15. Overt Release- relatively easy to recognise, emergency services will probably be involved first – priorities:  controlling area  identifying agent  giving health advice Covert Release- probably first recognised by health services  need for awareness against a background of atypical presentations of endemic disease Types of Deliberate Release

  16. Inhalation Powder Spray - Small scale - Large scale Explosive Contact/inoculation Fomites Explosive Ingestion Modes of Exposure

More Related